Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Mengge Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Sha…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Hepatitis B virus, Virus Integration, Histone-Lysine N-Methyltransferase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Projects Specialized in Infectious Diseases, National Key R&D Program of China.
Abstract (Originalsprache)
Background
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with few well‐established risk factors. Emerging epidemiological evidence suggests a link between hepatitis B virus (HBV) infection and PDAC. However, the underlying mechanisms remain unclear.
Methods
High‐throughput sequencing‐based approach was employed to identify HBV integrations in tumour and para‐tumour tissues of PDAC. The biological functions of KMT2B were evaluated in PDAC cell lines as well as in subcutaneous and orthotopic mouse models of PDAC. Chromatin immunoprecipitation sequencing and RNA sequencing were used to identify the pathway involved in PDAC development.
Results
HBV integration was detected in approximately one‐third of HBV DNA‐positive PDAC and adjacent para‐tumour tissues. A total of 425 viral‒host junctions were identified, with the majority located in intergenic regions (51.29%), followed by introns (43.29%) and exons (2.35%) of the human genome. Lysine methyltransferase 2B ( KMT2B , also known as MLL4 ), a gene frequently targeted by HBV integration in hepatocellular carcinoma, was also found to be interrupted by HBV in PDAC. KMT2B was significantly upregulated in PDAC and promoted malignant behaviours both in vitro and in vivo. Mechanistically, KMT2B exerts its oncogenic effects by regulating the downstream target gene FYN through histone H3K4 trimethylation, leading to the activation of the PI3K/Akt signalling pathway.
Conclusion
HBV integration is a common event in HBV‐related PDAC and KMT2B has been identified as a novel PDAC‐related gene. Key points Hepatitis B virus (HBV) integrates in both tumour and adjacent para‐tumour tissues of pancreatic ductal adenocarcinoma (PDAC). KMT2B , a target gene of HBV integration, promotes PDAC proliferation and metastasis in vivo and in vitro experiments. KMT2B exerts its oncogenic effects by regulating the downstream target gene FYN via histone H3K4 trimethylation, activating the PI3K/Akt signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Organ Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Shanghai Medical College, Fudan University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- National Key Projects Specialized in Infectious Diseases
- National Key R&D Program of China
- Chinese State Key Laboratory of Oncogenes and Related Genes
- Natural Science Foundation of Shanghai
- National Undergraduate Innovation and Entrepreneurship Training Program/FDUROP (Wangdao project)
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Li, M., Li, H., Liu, D., Liu, S., Yuan, H., Wu, Y., Du, M., Fang, Y., Li, J., Cong, H., Zhao, D., Fan, C., Wang, Q., Shen, C., Gan, Y., Sun, Y., & Tu, H. (2025). Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70424
Vancouver
Li M, Li H, Liu D, Liu S, Yuan H, Wu Y, et al. Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70424
BibTeX
@article{Li2025,
author = {Li, Mengge and Li, Huimin and Liu, Dejun and Liu, Shunan and Yuan, Hui and Wu, Yan and Du, Min and Fang, Yuan and Li, Jin and Cong, Hui and Zhao, Dan and Fan, Chunsun and Wang, Qing and Shen, Cenkai and Gan, Yu and Sun, Yongwei and Tu, Hong},
title = {Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70424}
}
EUVIMED